Miguel Ängelo Da Costa Garcia,Carlos Jorge Sousa De São José,Clara Isabel Rodrigues Leandro,Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva,Sara Ferreira Llorente Grancho Lourenço
申请号：
US13148009
公开号：
US20120052048A1
申请日:
2010.02.05
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophages F1245/05, F168/08, F170/08, F770/05, F197/08, F86/06, F87s/06 and F91a/06, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophages and/or isolated polypeptides and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies.
